ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nephrology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,098Medicare Part D Prescriptions Filled, Including Refills

Rank: 28 out of 749

$1.55M Total Retail Price of All Prescriptions

Rank: 10 out of 749

401 Patients Receiving at Least One Drug in Part D
50%Patients 65 Years and Older
85% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

9% of this provider’s 401 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

3% of this provider’s 4,205 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

34% of this provider’s prescriptions were for brand-name drugs, compared to an average of 31%.

Prescription Price

$154 was the average price of a prescription from this provider, compared to $116 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
AMLODIPINE BESYLATE 572 189 1 1
RENVELA 518 171 2 3
CARVEDILOL 495 175 3 11
SIMVASTATIN 345 150 4 5
SENSIPAR 328 60 5 8
FUROSEMIDE 296 119 6 2
OMEPRAZOLE 263 113 7 6
RENAGEL 245 59 10 8 50
METOPROLOL TARTRATE 224 59 9 7
ZOLPIDEM TARTRATE 210 74 10 24
INSULIN SYRINGE 195 75 11 41
LOSARTAN POTASSIUM 191 76 12 9
CLONIDINE HCL 174 42 13 15
GLIPIZIDE 168 74 14 32
LISINOPRIL 167 67 15 4
CALCITRIOL 164 118 16 17
GABAPENTIN 155 82 17 25
LANTUS 145 72 18 36
MINOXIDIL 130 34 19 59
ATORVASTATIN CALCIUM 129 78 20 18
BENAZEPRIL HCL 127 58 21 23
DIOVAN 125 60 22 14
PANTOPRAZOLE SODIUM 121 70 23 30
NAPROXEN 114 39 24 160
ACTOS 107 61 25 70
LEVOTHYROXINE SODIUM 105 61 26 13
FOSRENOL 104 0 10 27 76
METOCLOPRAMIDE HCL 104 40 27 74
TAMSULOSIN HCL 103 51 29 29
AZITHROMYCIN 103 50 29 65
CALCIUM ACETATE 98 32 31 16
LOVASTATIN 92 65 32 52
GLYBURIDE 87 27 R 33 103
HYDROCODONE-ACETAMINOPHEN 83 22 S3 34 12
PREDNISONE 81 27 35 28
MEGESTROL ACETATE 79 41 R 36 69
HYDROCHLOROTHIAZIDE 78 53 37 27
METFORMIN HCL 77 53 38 22
TRAMADOL HCL 77 42 38 47
TRIAMCINOLONE ACETONIDE 74 27 40 85
HYDRALAZINE HCL 72 21 41 19
WARFARIN SODIUM 67 28 42 31
ALLOPURINOL 64 31 43 10
ISOSORBIDE MONONITRATE ER 63 29 44 45
FAMOTIDINE 59 20 45 35
HUMALOG 59 38 45 112
CLONIDINE 59 14 45 174
CIPROFLOXACIN HCL 58 39 48 84
NOVOLIN 70-30 58 25 48 205
LABETALOL HCL 55 15 50 45
DIPHENOXYLATE-ATROPINE 53 15 51 177
CLOPIDOGREL 51 38 52 42
DOXAZOSIN MESYLATE 51 32 52 38
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 17, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.